Navigation Links
PDL BioPharma Announces First Quarter 2009 Financial Results
Date:5/7/2009

2009 2008 Cash, cash equivalents, short-term investments and restricted cash $193,192 $147,527 Total assets $219,065 $191,142 Total stockholders' deficit $(422,297) $(352,569) PDL BIOPHARMA, INC. CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW DATA (in thousands) (unaudited) Three Months Ended March 31, 2009 2008 Net income (loss) $37,457 $(61,875) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities (3,596) 33,769 Changes in assets and liabilities (6,148) (1,225) Net cash provided by (used in) operating activities $27,713 $(29,331)

                                     PDL BIOPHARMA, INC.
                   SUPPLEMENTAL INFORMATION ON DISCONTINUED OPERATIONS (1)
                                       (in thousands)
                                         (unaudited)

    Biotechnology Operations                              Three Months
                                                         Ended March 31,
                                                     2009              2008
    Net revenues                                     $-              $7,124
    Total costs and expenses                          -             (15,325)
    Income tax expense (benefit)                      -                 (3
'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Sinobiopharma Secures Rights to Seven Key Patents
2. China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
3. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
4. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
5. Helix BioPharma to Present at the BioFinance 2009 Conference
6. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
7. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
8. Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
9. Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry
10. XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
11. Sinobiopharma, Inc. Appoints New Director of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 27, 2015 , ... Visual Assay was named as a finalist ... most innovative technologies and services of the past year. More than 70 judges selected ... The winners will be announced at the 2015 R&D 100 Awards Dinner on November ...
(Date:7/24/2015)... 24, 2015 Ryan & Maniskas, LLP ... States District Court for the Northern District of ... that purchased the common stock of Avalanche Biotechnologies, Inc. ("Avalanche" ... 2014 and June 15, 2015, inclusive (the "Class Period"). ... move the Court for appointment as a lead plaintiff of ...
(Date:7/24/2015)... -- Champions Oncology (OTC-BB: CSBR), a company engaged in the ... the development and use of oncology drugs, today announced ... the fourth quarter and fiscal year quarter ended April ... open. The company will host a conference ... a.m. EDT (6:00 a.m. PDT). To participate in the ...
(Date:7/24/2015)... 2015 The global next ... 27.8 billion by 2022, growing at an estimated CAGR ... new study by Grand View Research, Inc. Development of ... result in significant reduction in cost of sequencing one ... usage rates of next generation sequencing throughout the forecast ...
Breaking Biology Technology:Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5
... A couple weeks ago, I asked, "Just what is this Web ... wide use of a phrase to label everything from start-ups ("Oh, ... site") to a point on the technology evolution timeline ("we're in ... question were almost as varied. , ,For Romasha Roy Choudhury ...
... - Merge Technologies, Inc. has received a written ... the company's failure to file financial reports for the quarter ... for delisting its common stock from NASDAQ. , ,Representatives ... before the NASDAQ Listing Qualifications Panel to request that the ...
... Milwaukee, Wis . - David Melbye hasn't been a ... has a significant information technology project under his belt. ... District , is wrapping up a major IT overhaul ... the district's governing commission. While he's pleased with the ...
Cached Biology Technology:Readers' Web 2.0 definitions 2Readers' Web 2.0 definitions 3Readers' Web 2.0 definitions 4CIO Leadership Series: David Melbye, Milwaukee Metro Sewerage District 2CIO Leadership Series: David Melbye, Milwaukee Metro Sewerage District 3CIO Leadership Series: David Melbye, Milwaukee Metro Sewerage District 4CIO Leadership Series: David Melbye, Milwaukee Metro Sewerage District 5
(Date:7/20/2015)... DENVER , July 20, 2015  Acuity ... Mobility Report: The Convergence of Commerce and Privacy" ... billion mobile biometric apps will be downloaded to ... users. The mobile biometrics market is projected to ... app revenue during the seven-year forecast period.    ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 30, 2015 after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... an extracellular matrix (ECM) containing proteins such as collagen, ... in regulating cell function. ECM proteins bind to integrins ... regulate cellular morphology, adhesion, cell migration, cell proliferation, and ... field, Extracellular Matrix Biology covers all aspects ...
... The world may seem painted with endless color, but ... red, green, and blue. Now a Tel Aviv University-developed ... analyze the world we live in. With the ability to ... Mr. Spock,s sci-fi "Tricorder," is being used to "diagnose" contaminants ...
... Shenzhen, China - BGI, the world,s largest genomic organization, ... the superior performance of RNA-Seq in predicting patient outcomes ... launched by the U.S. Food and Drug Administration (FDA). ... phase of the MicroArray Quality Control (MAQC), aimed at ...
Cached Biology News:Thousand-color sensor reveals contaminants in Earth and sea 2BGI to play a pivotal role in demonstrating the superior performance of RNA-Seq 2
... microarrays are derived from frozen embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... Sections are large (3-5mm in diameter) in ...
... The DNA Engine Opticon real-time PCR ... LEDs for fluorescence excitation (450-495 nm) and ... nm). The Opticon system is built on ... includes a thermal gradient feature. This item ...
... Precision-designed for Optimal Microdissection , CapSure HS ... precise and rapid extraction of populations of ... samples with Laser Capture Microdissection., Ensure ... Molecular Analysis , All CapSure LCM Caps ...
... VersArray ChipReader systems are highly sensitive ... of microarrays. These are advanced scanners that ... response and background level, and optimizing the ... the top end of the range for ...
Biology Products: